Puleva Biotech prevé elevar bº neto hasta 1,886 mln en 2007
MADRID (AFX-España) - Puleva Biotech SA espera obtener un beneficio neto de 1,886 millones de euros en 2007, frente a los 1,718 millones registrados en 2006, informa la compañía en un hecho relevante remitido a la CNMV.
tfn.europemadrid@thomson.com
rt/mm
COPYRIGHT
Copyright AFX News Limited 2007. All rights reserved.
The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.
AFX News and AFX Financial News Logo are registered trademarks of AFX News Limited